Get all your news in one place.
100's of premium titles.
One app.
Start reading
MarketBeat
MarketBeat
MarketBeat

MediWound Q1 Earnings Call Highlights

MediWound (NASDAQ:MDWD) reported a wider first-quarter loss and lower revenue compared with the prior-year period, while management reaffirmed its 2026 revenue outlook and said it continued to advance its EscharEx and NexoBrid programs.

On the company’s earnings call, Chief Executive Officer Ofer Gonen said MediWound “continued to execute against our key strategic priorities,” including moving EscharEx toward commercialization and expanding the global role of NexoBrid. He said the timeline for the EscharEx Phase III VALUE study has shifted by one quarter, but added that “the underlying momentum behind the program continues to strengthen.”

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.